{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:26:01Z","timestamp":1790616361715,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1995,5,1]],"date-time":"1995-05-01T00:00:00Z","timestamp":799286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[1995,5]]},"DOI":"10.1007\/bf02208342","type":"journal-article","created":{"date-parts":[[2005,10,5]],"date-time":"2005-10-05T19:27:08Z","timestamp":1128540428000},"page":"293-300","source":"Crossref","is-referenced-by-count":31,"title":["Serum levels of soluble forms of T cell activation antigens CD27 and CD25 in systemic lupus erythematosus in relation with lymphocytes count and disease course"],"prefix":"10.1007","volume":"14","author":[{"given":"A. J. G.","family":"Swaak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Q.","family":"Hintzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Huysen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. G.","family":"Van den Brink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. T.","family":"Smeenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02208342_CR1","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1126\/science.3131876","volume":"240","author":"K.A. Smith","year":"1988","unstructured":"Smith, K.A. Interleukin-2: inception, impact and implications. Science 1988, 240, 1169\u20131176.","journal-title":"Science"},{"key":"BF02208342_CR2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/scientificamerican0390-50","volume":"262","author":"K.A. Smith","year":"1990","unstructured":"Smith, K.A., Interleukin-2. Sci Am 1990, 262, 50\u201357.","journal-title":"Sci Am"},{"key":"BF02208342_CR3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1203\/00006450-198602000-00008","volume":"20","author":"D.L. Nelson","year":"1986","unstructured":"Nelson, D.L., Kurman, C.C., Fritz, M.E., Boutin, B., Rubin, L.A. Production of soluble and cellular Interleukin-2 receptors by cord blood mononuclear cells following in vitro activation. Pediatr Res 1986, 20, 136.","journal-title":"Pediatr Res"},{"key":"BF02208342_CR4","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.4049\/jimmunol.137.12.3841","volume":"137","author":"L.A. Rubin","year":"1986","unstructured":"Rubin, L.A., Jay, G., Nelson, D.L. The released Interleukin-2 receptor binds Interleukin-2 efficiently. J Immunol 1986, 137, 3841.","journal-title":"J Immunol"},{"key":"BF02208342_CR5","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.4049\/jimmunol.141.8.2612","volume":"8","author":"J.A. Symons","year":"1988","unstructured":"Symons, J.A., Wood, N.C., Di Giovine, F.S., Dull, G.W. Soluble IL-2 receptor in rheumatoid arthritis. J Immunol 1988, 8, 2612\u20132618.","journal-title":"J Immunol"},{"key":"BF02208342_CR6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2249.1990.tb05398.x","volume":"82","author":"E.J. Borg ter","year":"1991","unstructured":"ter Borg, E.J., Horst, G., Limburg, P.C., Kallenberg, C.G.M. Changes in plasma levels of Interleukin-2 receptor in relation to disease exacerbation and levels of anti-dsDNA and complement in systemic lupus erythematosus. Clin Exp Immunol 1991, 82, 21\u201326.","journal-title":"Clin Exp Immunol"},{"key":"BF02208342_CR7","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/ard.41.4.388","volume":"41","author":"A.J.G. Swaak","year":"1982","unstructured":"Swaak, A.J.G., Groenwold, J., Aarden, L.A. Statins van Eps, L.W., Feltkamp, T.E.W. Prognostic value of anti-dsDNA in systemic lupus erythematosus. Ann Rheum Dis 1982, 41, 388\u2013395.","journal-title":"Ann Rheum Dis"},{"key":"BF02208342_CR8","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.4049\/jimmunol.139.5.1589","volume":"139","author":"R.A.W. Lier van","year":"1987","unstructured":"van Lier, R.A.W., Borst, J., Vroom, Th.M., Klein, H., van Mourik, P., Zeylemaker, W.P., Melief, C.J.M. Tissue distribution and functional properties of Tp 55 (CD27) A novel T cell differentiation antigen. J Immunol 1987, 139, 1589\u20131596.","journal-title":"J Immunol"},{"key":"BF02208342_CR9","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.4049\/jimmunol.146.8.2488","volume":"146","author":"R. Jong de","year":"1991","unstructured":"de Jong, R., Loenen, W., Brouwer, M., van Emmerik, L., de Vries, E.F.R., Borst, J., van Lier, R.A.W. Regulation of expression of CD27, a T cell specific member of a novel family of membrane receptors. J Immunol 1991, 146, 2488\u20132494.","journal-title":"J Immunol"},{"key":"BF02208342_CR10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4049\/jimmunol.147.1.29","volume":"147","author":"R.Q. Hintzen","year":"1991","unstructured":"Hintzen, R.Q., de Jong, R., Hack, C.E., Chamuleau, M., de Vries, E.F.R., van Berge I.J.M., Borst, J., van Lier, R.A.W. A soluble form of the human T cell differentiation antigen. CD27 is released after triggering of the T cell receptor\/CD3 complex. J Immunol 1991, 147, 29\u201335.","journal-title":"J Immunol"},{"key":"BF02208342_CR11","unstructured":"De Jong, R. Activation and function of human T lymphocyte subsets. Thesis University Amsterdam 1992."},{"key":"BF02208342_CR12","doi-asserted-by":"crossref","unstructured":"Hol, B.E.A., Hintzen, R.Q., van Lier, R.A.W, Alberts P.C., Out, T.A., Jansen, H.M. Soluble and cellular markers of T cell activation in patients with pulmonary sarcoidosis. Am Rev Resp Dis, in press.","DOI":"10.1164\/ajrccm\/148.3.643"},{"key":"BF02208342_CR13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4049\/jimmunol.147.1.29","volume":"147","author":"R.Q. Hintzen","year":"1991","unstructured":"Hintzen, R.Q., de Jong, R., Hack C.E., Chamuleau, M., de Vries, E.F.R., den Berge, J.J.M., Borst, J., van Lier, R.A.W. A soluble form of the human T-cell differentiation antigen CD27 is released after triggering of the TCR\/CD3 complex. J Immunol 1991, 147, 29.","journal-title":"J Immunol"},{"key":"BF02208342_CR14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0165-5728(91)90175-7","volume":"35","author":"R.Q. Hintzen","year":"1991","unstructured":"Hintzen, R.Q., van Lier, R.A.W. Kuijpers, K.C., Baars, P.A., Schaasberg, W., Lucas, C.J., Polman, C.H. Elevated levels of a soluble form of the T cell activation antigen CD27 in cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol 1991, 35, 211.","journal-title":"J Neuroimmunol"},{"key":"BF02208342_CR15","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/00007890-199211000-00033","volume":"54","author":"M.E.D. Chamuleau","year":"1992","unstructured":"Chamuleau, M.E.D., ten Berge, J.J.M., Schellekens, P.T.A., Wilmink, J.M., Hintzen, R.Q., van Lier, R.A.W. Serum levels of soluble CD27 in renal transplant recipient. Transplantation 1992, 54, 932.","journal-title":"Transplantation"},{"key":"BF02208342_CR16","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.4049\/jimmunol.151.5.2426","volume":"151","author":"R.Q. Hintzen","year":"1993","unstructured":"Hintzen, R.Q., de Jong, R., Lens, S.M.A., Brouwer, M., Baars, P., van Lier, R.A.W., Regulation of CD27 expression in subsets T lymphocytes. J Immunol 1993, 151, 2426.","journal-title":"J Immunol"},{"key":"BF02208342_CR17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/art.1780210302","volume":"21","author":"S.J. Rivero","year":"1978","unstructured":"Rivero, S.J., Diaz-Jouanen, E., Alarcon-Segovia, D. Lymphopenia in systemic lupus erythematosus: clinical diagnostic and prognostic significance. Arthritis Rheum 1978, 21, 295\u2013305.","journal-title":"Arthritis Rheum"},{"key":"BF02208342_CR18","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/art.1780180609","volume":"18","author":"J.B. Winfield","year":"1975","unstructured":"Winfield, J.B., Winchester, R.J., Kunkel, H.G. Association of cold reactive antilymphocyte antibodies with lymphopenia in systemic lupus erythematosus. Arthritis Rheum 1975, 18, 587\u2013594.","journal-title":"Arthritis Rheum"},{"key":"BF02208342_CR19","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"E.M. Tan","year":"1982","unstructured":"Tan, E.M., Cohen, A.S., Fries, J.F., Masi, A.T., Mc Shane, D.J., Rothfield, N.F., Schaller, J.G., Talal, N., Winchester, R.J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25, 1271\u20131277.","journal-title":"Arthritis Rheum"},{"key":"BF02208342_CR20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/ard.40.1.45","volume":"40","author":"A.J.G. Swaak","year":"1981","unstructured":"Swaak, A.J.G., Groenwold, J., Aarden, L.A., Feltkamp, T.E.W. Detection of anti-dsDNA as a diagnostic tool. Ann Rheum Dis 1981, 40, 45\u201349.","journal-title":"Ann Rheum Dis"},{"key":"BF02208342_CR21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/ard.45.5.359","volume":"45","author":"A.J.G. Swaak","year":"1986","unstructured":"Swaak, A.J.G., Groenwold, J., Bronsveld, W. Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. Ann Rheum Dis 1986, 45, 359\u2013366. 22 Kassan, S.S., Lockskin, M.D. Central nervous system lupus erythematosus: the need for classification. Arthritis Rheum 1979, 22, 1382\u20131385.","journal-title":"Ann Rheum Dis"},{"key":"BF02208342_CR22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM198707303170503","volume":"317","author":"E. Bonfa","year":"1987","unstructured":"Bonfa, E., Golombek, S.J., Lee, D.K., Skelly, S., Weissback, H., Brot, N., Elkon, K.B. Association between lupus psychosis and anti-ribosomal protein antibodies. New Engl J Med 1987, 317, 265\u2013271.","journal-title":"New Engl J Med"},{"key":"BF02208342_CR23","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/art.1780311103","volume":"31","author":"D.H. Campen","year":"1988","unstructured":"Campen, D.H., Horwitz, D.A., Quismario, F.D., Ehresmann, G.R., Martin, W. Serum levels of Interleukin-2 receptor and activity of rheumatic diseases characterised by immune system activation. Arthritis Rheum 1988, 31, 1358\u20131364.","journal-title":"Arthritis Rheum"},{"key":"BF02208342_CR24","first-page":"524","volume":"19","author":"R.E. Wolf","year":"1992","unstructured":"Wolf, R.E., Brelsford, W.G., Hall, V.C., Adams, S.B. Cytokines and soluble Interleukin-2 receptors in rheumatoid arthritis. J Rheumatol 1992, 19, 524\u2013528.","journal-title":"J Rheumatol"},{"key":"BF02208342_CR25","first-page":"235","volume":"18","author":"M.M. Ward","year":"1991","unstructured":"Ward, M.M., Dooley, M.A., Christenson, V.D., Pisetsky, D.S. The relationship between soluble Interleukin-2 receptor levels and antidouble stranded DNA antibody levels in patients with systemic lupus erythematosus. J Rheumatol 1991, 18, 235\u2013240.","journal-title":"J Rheumatol"},{"key":"BF02208342_CR26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/ard.50.4.270-b","volume":"50","author":"P. Airo","year":"1991","unstructured":"Airo, P., Bettenzioli, M., Gorla, R., Cattaneo, R. Increased concentration of soluble Interleukin-2 receptor in serum of patients with systemic sclerosis. Ann Rheum Dis 1991, 50, 270\u2013271.","journal-title":"Ann Rheum Dis"},{"key":"BF02208342_CR27","first-page":"831","volume":"18","author":"S. Raziuddin","year":"1991","unstructured":"Raziuddin, S., Al-Janadi, W.A., Al-Wabel, A.A. Soluble Interleukin-2 receptor levels in serum and its relationship to T-cell abnormality and clinical manifestations of the disease in patients with Systemic Lupus Erythematosus. J Rheumatol 1991, 18, 831\u2013836.","journal-title":"J Rheumatol"},{"key":"BF02208342_CR28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0165-2478(86)90052-0","volume":"13","author":"K.K. Seth","year":"1986","unstructured":"Seth, K.K., Nahei. Elevated titers of cell-free Interleukin-2 receptor in serum and cerebrospinal fluid specimens of patients with acquired immunodeficiency syndrome Immunol Lett 1986, 13, 179\u2013184.","journal-title":"Immunol Lett"},{"key":"BF02208342_CR29","first-page":"10","volume":"69","author":"K.S.K. Turg","year":"1987","unstructured":"Turg, K.S.K., Kriland, E., Matznei, P. Soluble serum Interleukin-2 receptor levels in leprosy patients. Clin Exp Immunol 1987, 69, 10\u201315.","journal-title":"Clin Exp Immunol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02208342.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02208342\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02208342","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T23:37:20Z","timestamp":1683243440000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02208342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,5]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,5]]}},"alternative-id":["BF02208342"],"URL":"https:\/\/doi.org\/10.1007\/bf02208342","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,5]]}}}